New gene-editing therapy may lower cholesterol permanently, study finds |
A new experimental gene-editing treatment may one day offer a long-lasting solution for people with dangerously high cholesterol, potentially replacing the need for daily medication, according to early clinical trial results published in the New England Journal of Medicine.The therapy uses CRISPR-Cas9 technology to disable a gene called ANGPTL3, which plays a key role in…

